Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept

Adalimumab treatment with and without methotrexate in patients with moderate to severe psoriatic arthritis: Results from adept

Bibliographic Details
Main Authors:	Kavanaugh, A, Ritchlin, C, Malaise, MG, Wordsworth, P, Birbara, C, Weinberg, M
Format:	Conference item
Published:	2005

Similar Items

Radiographic efficacy of adalimumab in patients with psoriatic arthritis according to demographics, baseline clinical status, methotrexate use and clinical response: subanalysis of adept
by: Choy, E, et al.
Published: (2007)

Adalimumab in treatment of psoriatic arthritis
by: V. V. Badokin
Published: (2008-08-01)

Prediction and benefits of minimal disease activity in patients with psoriatic arthritis and active skin disease in the ADEPT trial
by: Mease, P, et al.
Published: (2017)

Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity
by: Landewé, R, et al.
Published: (2019)

Methotrexate in psoriasis and psoriatic arthritis
by: Coates, L, et al.
Published: (2020)

Methotrexate in a psoriatic arthritis patient
by: K. V. Aleksanyan, et al.
Published: (2022-12-01)

THE FIRST RUSSIAN EXPERIENCE OF ADALIMUMAB TREATMENT IN PSORIATIC ARTHRITIS
by: Elena Yurievna Loginova, et al.
Published: (2010-06-01)

Efficacy and safety of adalimumab in the treatment of Rheumatoid Arthritis (RA) in real-life clinical practice: 1-year-results of the react study
by: Burmester, G, et al.
Published: (2006)

Use of methotrexate in the treatment of psoriasis and psoriatic arthritis
by: Tatiana Viktorovna Korotaeva, et al.
Published: (2013-06-01)

New GRAPPA and EULAR recommendations for the management of psoriatic arthritis
by: Coates, L, et al.
Published: (2017)

Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis
by: A. V. Rudakova, et al.
Published: (2021-07-01)

Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis
by: Philip J Mease, et al.
Published: (2024-02-01)

The Efficacy of Combination Therapy by Adalimumab with Methotrexate and of Monotherapy by Methotrexate for Children Suffering from Polyarticular Juvenile Idiopathic Arthritis
by: V. A. Keltsev, et al.
Published: (2016-01-01)

Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
by: V. V. Didenko, et al.
Published: (2021-05-01)

Should methotrexate have any place in the treatment of psoriatic arthritis?
by: Ye, W, et al.
Published: (2019)

The effect of adalimumab on the vasculature in psoriatic skin lesions
by: S. C. A. Hanssen, et al.
Published: (2019-04-01)

Psoriatic arthritis
by: FitzGerald, O, et al.
Published: (2021)

Comparative efficacy of tofacitinib and adalimumab in patients with psoriatic arthritis in real clinical practice. Data from the Russian nationwide register of patients with psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2021-06-01)

Adalimumab and severe uveitis in juvenile idiopathic arthritis (JIA) therapy
by: Alpigiani MG, et al.
Published: (2008-09-01)

The influence of adalimumab treatment on the systemic gene expression in patients with psoriatic arthritis – preliminary report
by: Agata Krawczyk, et al.
Published: (2021-03-01)

Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis: an observational nationwide study
by: Ulf Lindström, et al.
Published: (2023-05-01)

Early treatment with addition of low dose prednisolone to methotrexate improves therapeutic outcome in severe psoriatic arthritis
by: Vikram K Mahajan, et al.
Published: (2013-01-01)

GRAPPA 2021 treatment recommendations for psoriatic arthritis
by: Soriano, ER, et al.
Published: (2023)

Comparison between adalimumab introduction and methotrexate dose escalation in patients with inadequately controlled psoriatic arthritis (CONTROL): a randomised, open-label, two-part, phase 4 study
by: Coates, LC, et al.
Published: (2022)

A case of vitiligo regression in a patient with psoriasis and psoriatic arthritis receiving adalimumab therapy
by: N. S. Rudneva, et al.
Published: (2021-12-01)

Efficacy and safety of baricitinib versus placebo and adalimumab in patients with moderately to severely active rheumatoid arthritis and inadequate response to methotrexate: Summary results from the 52-week phase 3 RA-beam study
by: Taylor, P, et al.
Published: (2017)

CHANGES OF CYTOKINE LEVELS DURING THERAPY WITH METHOTREXATE AND ADALIMUMAB IN PATIENTS WITH EARLY RHEUMATOID ARTHRITIS (REMARCA STUDY)
by: A. S. Avdeeva, et al.
Published: (2014-06-01)

Is drug discontinuation risk of adalimumab compared with etanercept affected by concomitant methotrexate dose in patients with rheumatoid arthritis?
by: Chen HH, et al.
Published: (2016-02-01)

RESULTS OF EVALUATING THE EFFICACY OF SECUKINUMAB VERSUS ADALIMUMAB IN TREATING PSORIATIC ARTHRITIS BY USING THE MATCHING-ADJUSTED INDIRECT COMPARISON METHOD
by: T. V. Korotaeva
Published: (2016-12-01)

COMPARATIVE EVALUATION OF THE EFFICACY AND SAFETY OF TREATMENT USING ADALIMUMAB IN COMBINATION WITH METHOTREXATE AND METHOTREXATE MONOTHERAPY IN CHILDREN WITH POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS IN COMBINATION WITH UVEITIS
by: V. А. Kel’tsev, et al.
Published: (2014-12-01)

CLINICAL ASSESSMENT IN PSORIATIC ARTHRITIS
by: M.G. Catanoso, et al.
Published: (2011-09-01)

Assessment of Liver Function among Patients with Rheumatoid Arthritis Versus Patients with Psoriatic Arthritis Treated by Methotrexate
by: Berevan Nozad Adham ,, et al.
Published: (2022-12-01)

Gastrointestinal disease and psoriatic arthritis.
by: Williamson, L, et al.
Published: (2004)

Time to response for clinical and patient-reported outcomes in patients with psoriatic arthritis treated with tofacitinib, adalimumab, or placebo
by: Gladman, DD, et al.
Published: (2022)

Time course of changes in lipid profile measures in patients with early psoriatic arthritis during adalimumab therapy
by: E. I. Markelova, et al.
Published: (2019-11-01)

FUNCTIONAL IMPAIRMENT IN PSORIATIC ARTHRITIS
by: Williamson, L, et al.
Published: (2004)

Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses
by: M. Ruiz-Ponce, et al.
Published: (2023-12-01)

MTHFR Gene Polymorphism Association With Psoriatic Arthritis Risk and the Efficacy and Hepatotoxicity of Methotrexate in Psoriasis
by: Jie Zhu, et al.
Published: (2022-04-01)

Endomysial antibodies in psoriatic arthritis patients.
by: Dockerty, J, et al.
Published: (2002)

An ADEPT apology reply
by: Pandit, J, et al.
Published: (2012)